Autophagy

Autophagy (Greek auto = self, phagein = to eat), literally means “eating oneself.” This biological process is an evolutionarily conserved mechanism that enables cells to degrade and recycle their own components. It involves the breakdown of damaged or nonfunctional organelles and proteins by lysosomal enzymes, followed by the recycling of their building blocks.

This intracellular process is triggered by various conditions such as physiological stress, starvation, infection and cellular aging. The degradative role of lysosomes in this process is central to maintaining cellular homeostasis.

The concept of autophagy was first defined in the 1960s by Christian de Duve, who observed it in rat liver cells and used the term “self-eating.” The molecular mechanisms were elucidated only in the 1990s through genetic and microscopic studies conducted by Yoshinori Ohsumi.

Ohsumi’s discovery of autophagy-related genes (Atg genes) in yeast cells enabled the identification of the molecular foundations of this process. This breakthrough revealed that autophagy is not merely a simple degradation pathway but a complex, regulated mechanism linked to disease.

Autophagy consists of five key stages occurring in a controlled manner within the cell:

1. Initiation: The formation of a double-membrane structure called the phagophore begins with the activation of the ULK1 complex (ULK1-Atg13-FIP200). This stage is typically triggered by the inhibition of mTORC1.
2. Elongation: During this phase, regulated by the PI3K complex (Beclin-1, Vps34, Atg14, etc.), the phagophore expands by incorporating lipids and begins to engulf target materials.
3. Vesicle Formation: The edges of the phagophore fuse to form a double-membraned autophagosome. The conjugation of the Atg8/LC3-II protein to the membrane plays a critical role in this stage.
4. Fusion: The autophagosome fuses with the lysosome via Rab7 and SNARE proteins, exposing its contents to lysosomal enzymes for degradation.
5. Degradation and Recycling: The degraded macromolecules (amino acids, fatty acids, sugars) are released into the cytoplasm and reused in cellular metabolism.

^{Otofaji Sürecinde Mitokondri Yıkımı Aşaması (Yapay Zeka Tarafından Oluşturulmuştur)}

Autophagy mechanisms are classified into three main categories:

• Macroautophagy: Organelles and large protein aggregates are degraded through the formation of autophagic vesicles. The attachment of LC3-II to the membrane is a defining feature of this process.
• Microautophagy: Small cytosolic components are directly taken up by invagination of the lysosomal membrane.
• Chaperone-Mediated Autophagy: Proteins containing a KFERQ motif bind to the Hsp70 chaperone system and are translocated directly into the lysosome via LAMP-2A. No vesicle formation occurs in this process.

In selective autophagy, specific structures are targeted. For example:

• Mitophagy (mitochondria),
• Ribophagy (ribosomes),
• Pexophagy (peroxisomes),
• Xenophagy (pathogens),
• Aggrephagy (protein aggregates)

Autophagy is essential for maintaining homeostasis, energy production, delaying aging and ensuring cellular quality control. Cells use this mechanism to eliminate damaged organelles, toxic proteins and foreign pathogens.

Moreover, autophagy plays a role in Type II programmed cell death. When cells cannot undergo apoptosis, they may die via autophagy. In this way, autophagy has a dual role, contributing to both cell survival and cell death.

Dysregulation or overactivation of autophagy is linked to numerous diseases:

• Cancer: In some cancer types, autophagy acts as a tumor suppressor; in others, it helps tumor cells survive under nutrient deprivation.
• Neurodegenerative diseases: In diseases such as Alzheimer’s and Parkinson’s, impaired degradation of misfolded proteins has made autophagy-targeted therapies increasingly important.
• Metabolic syndromes: Conditions such as diabetes, obesity and insulin resistance are associated with autophagy’s role in energy balance.

Autophagy is activated by prolonged fasting. When fasting, cells begin breaking down their own structural components to convert them into energy. Increased glucagon levels during this period trigger autophagy. Simultaneously, growth hormone secretion increases, supporting new cell formation.

In this context, intermittent fasting practices may reduce the risk of diseases such as Alzheimer’s and Parkinson’s by promoting autophagy. This process, which encourages cellular renewal, forms the basis of therapeutic fasting approaches in modern biomedical literature.

Autophagy is a fundamental process for cellular balance and health. By playing a critical role in energy management and cellular cleansing, it acts as a protective mechanism against disease. The regulation of autophagy in molecular biology is a major research area aimed at developing novel therapeutic strategies in modern medicine.